Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corporation

OCSL·NASDAQ

$11.81

-3.0%
Financial ServicesFinancial - Credit Services

Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.

At a Glance

Live Snapshot
Market Cap$1.04B
EPS0.3900
P/E Ratio30.28
Earnings Date08/04/2026
4.87%
Return on Invested Capital
168%
3Y+340.0%
5Y-
10Y-
2.31%
Return on Equity
-41%
3Y-1.0%
5Y-46.0%
10Y-140.0%
1.13%
Return on Assets
-38%
3Y+2.0%
5Y-53.0%
10Y-140.0%
Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corporation Management Team

OCSL · NASDAQ
MA

Ms. Ashley Pak

Chief Compliance Officer

Born 1978(Age 48)
female
MA

Mr. Armen Panossian J.D.

Chief Executive Officer & Co-Chief Investment Officer

Born 1976(Age 50)
male
MR

Mr. Raghav Khanna

Co-Chief Investment Officer

Born 1984(Age 42)
male
MC

Mr. Christopher McKown

MD,Chief Financial Officer & Treasurer

Born 1982(Age 44)
male
MM

Ms. Mary Gallegly J.D.

MD,General Counsel & Secretary

female
DA

Dr. Aman Kumar M.D.

Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending

Born 1981(Age 45)
MS

Mr. Sandeep Kumar Khorana

Managing Director of Origination

Born 1973(Age 53)
male
MM

Mr. Mathew M. Pendo

President

Born 1964(Age 62)
male
ML

Ms. Lucia S. Kim

Senior Vice President

female
MD

Mr. Dane Kleven

Senior Vice President & Head of Investor Relations

male
ocsl

Oaktree Specialty Lending Corporation Insider Positioning

OCSL · NASDAQ

During the last 12 months, insiders have purchased $40K worth of OCSL shares, with no selling activity reported.

3 Months

Bought

2.5K

26.93K

Sold

0

0.00

Net Activity

+27K

+$27K

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

975

12.87K

Sold

0

0.00

Net Activity

+13K

+$13K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

1
CPR

Caldwell Phyllis R

Director

3.5K shares2 transactions

$40K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $40K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

∞:1

Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.

Recent Trend (3 Months)

$27K

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

High Buying

1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.

SEC Filings

OCSL - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

January 16, 2026
March 03, 2026
2026
DEF 14A

DEF 14A 2026

N/A

January 08, 2026
March 03, 2026
2026
DEF 14A

DEF 14A 2025

N/A

January 17, 2025
March 04, 2025
2025
DEF 14A

DEF 14A 2025

N/A

January 10, 2025
March 04, 2025
2025
DEF 14A

DEF 14A 2024

N/A

January 19, 2024
March 04, 2024
2024
DEF 14A

DEF 14A 2024

N/A

January 10, 2024
March 04, 2024
2024
DEF 14A

DEF 14A 2023

N/A

February 06, 2023
March 17, 2023
2023
DEF 14A

DEF 14A 2022

N/A

January 20, 2022
March 04, 2022
2022
DEF 14A

DEF 14A 2022

N/A

January 13, 2022
March 04, 2022
2022
DEF 14A

DEF 14A 2020

N/A

January 13, 2020
March 09, 2020
2020
Showing 1 to 10 of 25 filings